These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Journal Abstract Search

184 related items for PubMed ID: 9787233

  • 1.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 2.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 3.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 4.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 5.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 6.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 7. Diverse NF-kappaB expression in epiretinal membranes after human diabetic retinopathy and proliferative vitreoretinopathy.
    Harada C, Harada T, Mitamura Y, Quah HM, Ohtsuka K, Kotake S, Ohno S, Wada K, Takeuchi S, Tanaka K.
    Mol Vis; 2004 Jan 15; 10():31-6. PubMed ID: 14737065
    [Abstract] [Full Text] [Related]

  • 8. Outcome of vitreous surgery and the balance between vascular endothelial growth factor and endostatin.
    Funatsu H, Yamashita H, Noma H, Mochizuki H, Mimura T, Ikeda T, Hori S.
    Invest Ophthalmol Vis Sci; 2003 Mar 15; 44(3):1042-7. PubMed ID: 12601027
    [Abstract] [Full Text] [Related]

  • 9. Vitreous vascular endothelial growth factor concentrations in proliferative diabetic retinopathy versus proliferative vitreoretinopathy.
    Citirik M, Kabatas EU, Batman C, Akin KO, Kabatas N.
    Ophthalmic Res; 2012 Mar 15; 47(1):7-12. PubMed ID: 21691136
    [Abstract] [Full Text] [Related]

  • 10. Different expression of vascular endothelial growth factor and pigment epithelium-derived factor between diabetic and non-diabetic epiretinal membranes.
    Nam DH, Oh J, Roh JH, Huh K.
    Ophthalmologica; 2009 Mar 15; 223(3):188-91. PubMed ID: 19182495
    [Abstract] [Full Text] [Related]

  • 11. Apoptosis and cell proliferation in proliferative retinal disorders: PCNA, Ki-67, caspase-3, and PARP expression.
    Zhang X, Barile G, Chang S, Hays A, Pachydaki S, Schiff W, Sparrow J.
    Curr Eye Res; 2005 May 15; 30(5):395-403. PubMed ID: 16020270
    [Abstract] [Full Text] [Related]

  • 12. Vitreous and plasma concentrations of apelin and vascular endothelial growth factor after intravitreal bevacizumab in eyes with proliferative diabetic retinopathy.
    Qian J, Lu Q, Tao Y, Jiang YR.
    Retina; 2011 Jan 15; 31(1):161-8. PubMed ID: 20890241
    [Abstract] [Full Text] [Related]

  • 13.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 14.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 15. Immunohistochemical study of extracellular matrix components in epiretinal membranes of vitreoproliferative retinopathy and proliferative diabetic retinopathy.
    Ioachim E, Stefaniotou M, Gorezis S, Tsanou E, Psilas K, Agnantis NJ.
    Eur J Ophthalmol; 2005 Jan 15; 15(3):384-91. PubMed ID: 15945009
    [Abstract] [Full Text] [Related]

  • 16. The angiogenic biomarker endocan is upregulated in proliferative diabetic retinopathy and correlates with vascular endothelial growth factor.
    Abu El-Asrar AM, Nawaz MI, De Hertogh G, Al-Kharashi AS, Van den Eynde K, Mohammad G, Geboes K.
    Curr Eye Res; 2015 Mar 15; 40(3):321-31. PubMed ID: 24871583
    [Abstract] [Full Text] [Related]

  • 17. Upregulation of RAGE and its ligands in proliferative retinal disease.
    Pachydaki SI, Tari SR, Lee SE, Ma W, Tseng JJ, Sosunov AA, Cataldergirmen G, Scarmeas N, Caspersen C, Chang S, Schiff WM, Schmidt AM, Barile GR.
    Exp Eye Res; 2006 May 15; 82(5):807-15. PubMed ID: 16364297
    [Abstract] [Full Text] [Related]

  • 18. Vascular endothelial growth factor levels in vitreous and serum of patients with either proliferative diabetic retinopathy or proliferative vitreoretinopathy.
    Sydorova M, Lee MS.
    Ophthalmic Res; 2005 May 15; 37(4):188-90. PubMed ID: 15990461
    [Abstract] [Full Text] [Related]

  • 19. [Pathomorphology of membranes appearing in proliferative vitreoretinopathies].
    Laudańska-Olszewska I, Omulecki W, Dziegielewski K, Pikulski Z, Omulecka A.
    Klin Oczna; 2006 May 15; 108(1-3):28-31. PubMed ID: 16883935
    [Abstract] [Full Text] [Related]

  • 20. Chemokines in proliferative diabetic retinopathy and proliferative vitreoretinopathy.
    Abu El-Asrar AM, Struyf S, Kangave D, Geboes K, Van Damme J.
    Eur Cytokine Netw; 2006 Sep 15; 17(3):155-65. PubMed ID: 17194635
    [Abstract] [Full Text] [Related]

    Page: [Next] [New Search]
    of 10.